| Gufic BioSciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 509079 |
NSE Symbol : GUFICBIO |
P/E(TTM) : 56.37 |
|
ISIN Demat : INE742B01025 |
Div & Yield% : 0.03 |
EPS(TTM) : 5.42 |
|
Book Value(₹) : 62.68 |
Market Cap(₹Cr) : 3,064.13 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 230.42 | 226.91 | 205.02 | 207.79 | 204.18 | 202.81 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 230.42 | 226.91 | 205.02 | 207.79 | 204.18 | 202.81 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.09 | 0.89 | 0.38 | 1.86 | 0.11 | 1.25 |
| Total Income | 232.51 | 227.81 | 205.40 | 209.66 | 204.29 | 204.07 |
| Total Expenditure | 194.62 | 194.58 | 178.38 | 173.85 | 165.56 | 167.03 |
| PBIDT | 37.89 | 33.23 | 27.02 | 35.81 | 38.74 | 37.04 |
| Interest | 9.58 | 9.23 | 8.40 | 4.91 | 5.18 | 4.62 |
| PBDT | 28.30 | 24.00 | 18.62 | 30.90 | 33.56 | 32.41 |
| Depreciation | 7.77 | 7.72 | 7.84 | 4.62 | 4.30 | 4.31 |
| Tax | 3.55 | 2.22 | 0.29 | 3.95 | 7.50 | 7.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.04 | 1.98 | 2.51 | 3.01 | -0.01 | 0.25 |
| Reported Profit After Tax | 14.94 | 12.07 | 7.97 | 19.32 | 21.78 | 20.86 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 14.94 | 12.07 | 7.97 | 19.32 | 21.78 | 20.86 |
| EPS (Unit Curr.) | 1.49 | 1.20 | 0.80 | 1.93 | 2.17 | 2.08 |
| EPS (Adj) (Unit Curr.) | 1.49 | 1.20 | 0.80 | 1.93 | 2.17 | 2.08 |
| Calculated EPS (Unit Curr.) | 1.49 | 1.20 | 0.80 | 1.93 | 2.17 | 2.08 |
| Calculated EPS (Adj) (Unit Curr.) | 1.49 | 1.20 | 0.80 | 1.93 | 2.17 | 2.08 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.96 | 4.82 | 3.18 | 7.71 | 8.69 | 8.32 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.96 | 4.82 | 3.18 | 7.71 | 8.69 | 8.32 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.03 | 10.03 | 10.03 | 10.03 | 10.03 | 10.03 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.44 | 14.64 | 13.18 | 17.23 | 18.97 | 18.26 |
| PBDTM(%) | 12.28 | 10.58 | 9.08 | 14.87 | 16.44 | 15.98 |
| PATM(%) | 6.48 | 5.32 | 3.89 | 9.30 | 10.67 | 10.29 |